Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

57.18
Delayed Data
As of Jul 29
 +1.09 / +1.94%
Today’s Change
35.37
Today|||52-Week Range
169.16
-10.96%
Year-to-Date
3 Biotech Stocks to Buy on Sale
9:07am / MotleyFool.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content
4 Stocks to Play In Today's Market
Jul 28 / TheStreet.com - Paid Partner Content
This Could Be the Next Big Pharma Buyout
Jul 18 / MotleyFool.com - Paid Partner Content
5 Reasons bluebird bio Inc. Took Flight Today
Jul 27 / MotleyFool.com - Paid Partner Content
Cancer drug trial deaths hit biotech industry
Jul 08 / FT.com - Paid Partner Content
Bluebird Bio (BLUE) Marked As A Barbarian At The Gate
Jul 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close56.09
Today’s open55.81
Day’s range55.44 - 57.97
Volume737,302
Average volume (3 months)1,004,507
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-162.84%
Earnings growth (this year)-26.36%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)-44.62%
P/E ratioNM
Price/Sales158.14
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+1.19+7.39%
NVAXNovavax Inc-0.06-0.81%
RDUSRadius Health Inc+1.32+2.88%
OPHTOphthotech Corp-0.79-1.21%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$1.50
Annual revenue (last year)$14.1M
Annual profit (last year)-$166.8M
Net profit margin-1,184.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Medical Officer
David M. Davidson
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs